| HOME >> MEDICINE >> TECHNOLOGY |
Table 148: Menarini Group, The: key facts 249
Table 149: Takeda Pharmaceutical Company Limited: key facts 250
Table 150: Takeda Pharmaceutical Company Limited: key financials ($) 251
Table 151: Takeda Pharmaceutical Company Limited: key financials (¥) 251
Table 152: Takeda Pharmaceutical Company Limited: key financial ratios 251
Table 153: Mitsubishi Tanabe Pharma Corporation: key facts 253
Table 154: Mitsubishi Tanabe Pharma Corporation: key financials ($) 254
Table 155: Mitsubishi Tanabe Pharma Corporation: key financials (¥) 254
Table 156: Mitsubishi Tanabe Pharma Corporation: key financial ratios 254
Table 157: Johnson & Johnson: key facts 256
Table 158: Johnson & Johnson: key financials ($) 257
Table 159: Johnson & Johnson: key financial ratios 257
Table 160: Jiangsu Yangtze River Pharmaceutical Group Company Ltd.: key facts 259
Table 161: Almirall S.A.: key facts 260
Table 162: Almirall S.A.: key financials ($) 260
Table 163: Almirall S.A.: key financials (€) 261
Table 164: Almirall S.A.: key financial ratios 261
Table 165: Sanofi: key facts 263
Table 166: Sanofi: key financials ($) 264
Table 167: Sanofi: key financials (€) 264
Table 168: Sanofi: key financial ratios 265
LIST OF FIGURESFigure 1: Global pharmaceuticals market value: $ billion, 2007–11 25Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2011 26Figure 3: Global pharmaceuticals market share: % share, by value, 2011 27Figure 4: Global pharmaceuticals market value forecast: $ billion, 2011–16 28Figure 5: Forces driving competition in the global pharmaceuticals market, 2011 29Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2011 30Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2011 32Figure 8: Factor
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |